NCT04828681

Brief Summary

Coronary microcirculatory dysfunction has been known to be prevalent even after successful revascularization of ST-segment elevation myocardial infarction (STEMI) patients. Microvascular obstruction (MVO) in cardiac magnetic resonance (CMR) is significant prognostic indicator in STEMI patients after primary percutaneous coronary intervention (PCI). Although current gold-standard method to assess microvascular damage or dysfunction in STEMI patients is CMR and assessment of MVO, previous study presented that index of microcirculatory resistance (IMR) in culprit vessel of STEMI patients showed significant association with the presence of MVO in CMR and the risk of cardiac death or heart failure admission. Nevertheless, the need for pressure-temperature sensor wire and hyperemic agents significantly limits adoption of IMR in daily practice. Recent technical development enabled angiographic derivation of IMR without pressure wire, hyperemic agents, or thermodilution method. In this regard, the current study will evaluate the feasibility of functional angiography-derived IMR (angio-IMR) in the evaluation of MVO after successful primary PCI for STEMI.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
324

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2007

Longer than P75 for all trials

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 24, 2007

Completed
13.3 years until next milestone

First Submitted

Initial submission to the registry

March 30, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 2, 2021

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2021

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

March 14, 2025

Status Verified

March 1, 2025

Enrollment Period

14 years

First QC Date

March 30, 2021

Last Update Submit

March 12, 2025

Conditions

Keywords

ST-segment Elevation Myocardial Infarction (STEMI)Index of microcirculatory resistanceCardiac magnetic resonance imagingMicrovascular obstructionCoronary microcirculation

Outcome Measures

Primary Outcomes (1)

  • Proportion of microvascular obstruction in CMR

    Proportion of microvascular obstruction in CMR

    At the time of index hospitalization

Secondary Outcomes (7)

  • Correlation of angio-IMR with the extent of microvascular obstruction in CMR

    At the time of index hospitalization

  • Correlation of angio-IMR with the infarct size in CMR

    At the time of index hospitalization

  • Correlation of angio-IMR with the area at risk in CMR

    At the time of index hospitalization

  • Correlation of angio-IMR with the myocardial salvage index in CMR

    At the time of index hospitalization

  • Discrimination ability of angio-IMR to predict the occurrence of microvascular obstruction in CMR

    At the time of index hospitalization

  • +2 more secondary outcomes

Study Arms (2)

Patients with Angio-IMR>40 Unit

Patients with angio-IMR\>40U in the culprit vessel after successful primary PCI.

Diagnostic Test: Cardiac magnetic resonance imaging

Patients with Angio-IMR≤40 Unit

Patients with angio-IMR≤40U in the culprit vessel after successful primary PCI.

Diagnostic Test: Cardiac magnetic resonance imaging

Interventions

Cardiac magnetic resonance imaging was performed 5.0 ± 5.8 days after the primary PCI. MVO, infarct size, and myocardial salvage index were quantitatively assessed in CMR.

Patients with Angio-IMR>40 UnitPatients with Angio-IMR≤40 Unit

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population will be derived from the prospective institutional AMI registry of Samsung Medical Center between December 2007 and July 2014. In this registry, 515 consecutive patients who presented with acute myocardial infarction and underwent CMR were prospectively enrolled. Among the total patients, STEMI patients (n = 332) will be analyzed for the current study. For the study purpose, patients with failed primary PCI (n=1), treated by medical treatment alone without PCI (n=4), and no available coronary angiographic images (n=3) will be excluded. Among the remaining 324 patients, patients with insufficient image quality for angio-IMR calculation will be additionally excluded (n=37).

You may qualify if:

  • STEMI patients
  • Successful primary PCI in the culprit vessel
  • Underwent cardiac MR during index hospitalization
  • Suitable coronary angiographic images for angio-IMR analysis

You may not qualify if:

  • patients with failed primary PCI
  • treated by medical treatment alone without PCI
  • no available coronary angiographic images
  • insufficient image quality for angio-IMR calculation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Iowa Carver College of Medicine, Iowa City, IA, USA

Iowa City, Iowa, United States

Location

Shanghai Institute of Cardiovascular Diseases, Shanghai, China

Shanghai, Shanghai Municipality, China

Location

Related Publications (1)

  • Shin D, Kim J, Choi KH, Dai N, Li Y, Lee SH, Joh HS, Kim HK, Kim SM, Ha SJ, Jang MJ, Park TK, Yang JH, Song YB, Hahn JY, Choi SH, Choe YH, Gwon HC, Lee JM. Functional angiography-derived index of microcirculatory resistance validated with microvascular obstruction in cardiac magnetic resonance after STEMI. Rev Esp Cardiol (Engl Ed). 2022 Oct;75(10):786-796. doi: 10.1016/j.rec.2022.01.004. Epub 2022 Mar 3. English, Spanish.

MeSH Terms

Conditions

ST Elevation Myocardial Infarction

Condition Hierarchy (Ancestors)

Myocardial InfarctionMyocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosis

Study Officials

  • Joo Myung Lee, MD, MPH, PhD

    Samsung Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

March 30, 2021

First Posted

April 2, 2021

Study Start

December 24, 2007

Primary Completion

December 31, 2021

Study Completion

December 31, 2023

Last Updated

March 14, 2025

Record last verified: 2025-03

Locations